AGL 38.02 Increased By ▲ 0.08 (0.21%)
AIRLINK 197.36 Increased By ▲ 3.45 (1.78%)
BOP 9.54 Increased By ▲ 0.22 (2.36%)
CNERGY 5.91 Increased By ▲ 0.07 (1.2%)
DCL 8.82 Increased By ▲ 0.14 (1.61%)
DFML 35.74 Decreased By ▼ -0.72 (-1.97%)
DGKC 96.86 Increased By ▲ 4.32 (4.67%)
FCCL 35.25 Increased By ▲ 1.28 (3.77%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.17 Increased By ▲ 0.42 (3.29%)
HUBC 127.55 Increased By ▲ 6.94 (5.75%)
HUMNL 13.50 Decreased By ▼ -0.10 (-0.74%)
KEL 5.32 Increased By ▲ 0.10 (1.92%)
KOSM 7.00 Increased By ▲ 0.48 (7.36%)
MLCF 44.70 Increased By ▲ 2.59 (6.15%)
NBP 61.42 Increased By ▲ 1.61 (2.69%)
OGDC 214.67 Increased By ▲ 3.50 (1.66%)
PAEL 38.79 Increased By ▲ 1.21 (3.22%)
PIBTL 8.25 Increased By ▲ 0.18 (2.23%)
PPL 193.08 Increased By ▲ 2.76 (1.45%)
PRL 38.66 Increased By ▲ 0.49 (1.28%)
PTC 25.80 Increased By ▲ 2.35 (10.02%)
SEARL 103.60 Increased By ▲ 5.66 (5.78%)
TELE 8.30 Increased By ▲ 0.08 (0.97%)
TOMCL 35.00 Decreased By ▼ -0.03 (-0.09%)
TPLP 13.30 Decreased By ▼ -0.25 (-1.85%)
TREET 22.16 Decreased By ▼ -0.57 (-2.51%)
TRG 55.59 Increased By ▲ 2.72 (5.14%)
UNITY 32.97 Increased By ▲ 0.01 (0.03%)
WTL 1.60 Increased By ▲ 0.08 (5.26%)
BR100 11,727 Increased By 342.7 (3.01%)
BR30 36,377 Increased By 1165.1 (3.31%)
KSE100 109,513 Increased By 3238.2 (3.05%)
KSE30 34,513 Increased By 1160.1 (3.48%)

A treatment for alcoholism can reactivate dormant HIV, potentially allowing other drugs to spot and kill the virus hiding out in human immune cells, researchers said. The medication, called Disulfiram, draws out the AIDS-causing virus without any side effects for patients, according to a study published in The Lancet.
In people undergoing treatment for AIDS, the virus can take cover in certain cells and hide away, only to reemerge once therapy is stopped.
This latency has been one of the biggest hurdles in developing a cure. "Waking up" the virus - and then destroying it - is a promising strategy for ridding patients of HIV.
But other drugs which are able to rouse HIV from its dormant state are toxic to humans.
In clinical trials led by Sharon Lewin, a professor at the University of Melbourne, 30 people on antiretroviral treatment (ART) were given increasing doses of Disulfiram over a period of three days.
At the highest dose, there was evidence of slumbering HIV being stimulated, with no side effects.
"This trial clearly demonstrates that Disulfiram is not toxic and is safe to use, and could quite possibly be the game changer we need," Lewin said in a statement.
The next step will be to test Disulfiram's rousing effect in combination with a virus-killing drug.
"Waking up the virus is only the first step to eliminating it," said the study's lead author Julian Elliott, head of clinical research in the department of infectious diseases at Alfred Hospital in Melbourne, Australia.
"Now we need to work out how to get rid of the infected cell." Approximately 34 million people have died of HIV-related causes world-wide. By the end of 2014, there were an estimated 36.9 people living with HIV globally.

Copyright Agence France-Presse, 2015

Comments

Comments are closed.